Microphysiological Systems: Stakeholder Challenges to Adoption in Drug Development-Reference-Cited by-同舟云学术

Microphysiological Systems: Stakeholder Challenges to Adoption in Drug Development

Published:2021-08-11 Issue: Volume: Page:1-13
ISSN:1422-6405
Container-title:Cells Tissues Organs
language:en
Short-container-title:Cells Tissues Organs

Author:

Hargrove-Grimes Passley^ORCID,Low Lucie A.,Tagle Danilo A.

Abstract

Microphysiological systems (MPS) or tissue chips/organs-on-chips are novel <i>in vitro</i> models that emulate human physiology at the most basic functional level. In this review, we discuss various hurdles to widespread adoption of MPS technology focusing on issues from multiple stakeholder sectors, e.g., academic MPS developers, commercial suppliers of platforms, the pharmaceutical and biotechnology industries, and regulatory organizations. Broad adoption of MPS technology has thus far been limited by a gap in translation between platform developers, end-users, regulatory agencies, and the pharmaceutical industry. In this brief review, we offer a perspective on the existing barriers and how end-users may help surmount these obstacles to achieve broader adoption of MPS technology.

Publisher

S. Karger AG

Subject

Histology,Anatomy

Reference96 articles.

1. Ahn SI, Sei YJ, Park HJ, Kim J, Ryu Y, Choi JJ, et al. Microengineered human blood-brain barrier platform for understanding nanoparticle transport mechanisms. Nat Commun. 2020;11(1):175.

2. Ainslie GR, Davis M, Ewart L, Lieberman LA, Rowlands DJ, Thorley AJ, et al. Microphysiological lung models to evaluate the safety of new pharmaceutical modalities: a biopharmaceutical perspective. Lab Chip. 2019;19(19):3152–61.

3. Arrowsmith J. Trial watch: Phase II failures: 2008-2010. Nat Rev Drug Discov. 2011;10(5):328–9.

4. Arrowsmith J. Trial watch: phase III and submission failures: 2007-2010. Nat Rev Drug Discov. 2011;10(2):87.

5. Arrowsmith J, Miller P. Trial watch: phase II and phase III attrition rates 2011-2012. Nat Rev Drug Discov. 2013;12(8):569.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A (not) new Rx: Quality Improvement for NAM;Regulatory Toxicology and Pharmacology;2024-02

2. Review on new approach methods to gain insight into the feto-maternal interface physiology;Frontiers in Medicine;2023-11-30

3. Pumped and pumpless microphysiological systems to study (nano)therapeutics;WIREs Nanomedicine and Nanobiotechnology;2023-07-18

4. A Next-Generation 3D Tissue-Engineered Model of the Human Brain Microvasculature to Study the Blood-Brain Barrier;Bioengineering;2023-07-08

5. Microphysiological Systems for Cancer Immunotherapy Research and Development;Advanced Biology;2023-07-06